Armistice Capital, LLC Xencor Inc Transaction History
Armistice Capital, LLC
- $6.02 Billion
- Q3 2024
A detailed history of Armistice Capital, LLC transactions in Xencor Inc stock. As of the latest transaction made, Armistice Capital, LLC holds 478,000 shares of XNCR stock, worth $12.7 Million. This represents 0.16% of its overall portfolio holdings.
Number of Shares
478,000
Previous 864,000
44.68%
Holding current value
$12.7 Million
Previous $16.4 Million
41.23%
% of portfolio
0.16%
Previous 0.21%
Shares
7 transactions
Others Institutions Holding XNCR
# of Institutions
216Shares Held
71.8MCall Options Held
2.5KPut Options Held
7.9K-
Black Rock Inc. New York, NY11.1MShares$295 Million0.0% of portfolio
-
Primecap Management CO Pasadena, CA9.14MShares$243 Million0.14% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.6MShares$202 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA5.33MShares$142 Million4.65% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.93MShares$105 Million0.01% of portfolio
About Xencor Inc
- Ticker XNCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,698,100
- Market Cap $1.59B
- Description
- Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...